Janssen submits Marketing Authorisation Application for daratumumab for European patients with heavily pre-treated multiple myeloma
- EMEA Innovative Medicine
- Janssen submits Marketing Authorisation Application for daratumumab for European patients with heavily pre-treated multiple myeloma
Janssen submits Marketing Authorisation Application for daratumumab for European patients with heavily pre-treated multiple myeloma
- X (Twitter)
Copy link